The use of immunological drugs for the treatment of wound infections in military personnel during hostilities
DOI:
https://doi.org/10.57125/FEM.2024.03.30.06Keywords:
wound infections, military personnel, hostilities, immunological drugs, treatmentAbstract
Aims: To assesses the trends in immunological drug development for managing wound infections in military personnel. To discuss the efficacy, safety, and long-term results, focusing on combination therapies, and identifying research deficits for improving the care of military wounds.
Methodology: A narrative review was used in order to explores the use of immunological drugs for treating wound infections in military settings utilising a search strategy identified 840 publications from PubMed, with 6 studies meeting inclusion criteria for analysis from the years 2019 to 2022.
Results: The narrative review concerning the use of immunological drugs for treating wound infections in military personnel during hostilities revealed an increasing trend in research interest from 2000 to 2024, with a significant rise from 7 publications in 2000 and 2001 to a peak of 72 in 2018, followed by a descent to 19 in 2021 likely due to the COVID-19 pandemic, and a slight recovery to 41 in 2022. The key findings included a 50% reduction in infection rates and a 30% faster healing time with monoclonal antibody treatments, over 95% accuracy in species identification of MDR strains, and reduced bacteremia incidence with GM-CSF and G-CSF. Adverse effects varied from mild to moderate, including infusion reactions, nausea, and fatigue. The highlighted challenges included the need for larger sample sizes, long-term follow-up, optimal dosages, and studying diverse populations.
Scientific Novelty: Explore the innovative realm of immunological drugs, a promising frontier in combating wound infections among military personnel during active hostilities.
Conclusion: The review also identified new developments in immunomodulatory agents for military wound infection, which are effective in decreasing infection rates and enhancing the rate of wound healing.
References
Petfield JL, Lewandowski LR, Stewart L, Murray CK, Tribble DR. IDCRP Combat-Related Extremity Wound Infection Research. Mil Med 2022;187:25–33. https://doi.org/10.1093/MILMED/USAB065.
Nawfal Dagher T, Al-Bayssari C, Diene SM, Azar E, Rolain JM. Bacterial infection during wars, conflicts and post-natural disasters in Asia and the Middle East: a narrative review. Expert Rev Anti Infect Ther 2020;18:511–29. https://doi.org/10.1080/14787210.2020.1750952.
Breeze J, Bowley DM, Combes JG, Baden J, Orr L, Beggs A, et al. Outcomes following penetrating neck injury during the Iraq and Afghanistan conflicts: A comparison of treatment at US and United Kingdom medical treatment facilities. J Trauma Acute Care Surg 2020;88:696. https://doi.org/10.1097/TA.0000000000002625.
Liu GD, Wang N, Wang HM, Li X, Shao JJ, Liu ZF, et al. Military medical research on internal diseases in modern warfare: new concepts, demands, challenges, and opportunities. Mil Med Res 2021;8:1–5. https://doi.org/10.1186/S40779-021-00313-8/METRICS.
Nahid MA, Griffin JM, Lustik MB, Hayes JJ, Fong KSK, Horseman TS, et al. A longitudinal evaluation of the bacterial pathogens colonizing chronic non-healing wound sites at a united states military treatment facility in the pacific region. Infect Drug Resist 2021;14:1–10. https://doi.org/10.2147/IDR.S260708.
Gede D, Mangku S. Roles and Actions That Should Be Taken by The Parties In The War In Concerning Wound and Sick Or Dead During War or After War Under The Geneva Convention 1949. Jurnal Komunikasi Hukum (JKH) 2021;7:170–8. https://doi.org/10.23887/JKH.V7I1.31467.
Caldwell MD. Bacteria and Antibiotics in Wound Healing. Surgical Clinics 2020;100:757–76. https://doi.org/10.1016/J.SUC.2020.05.007.
McIntyre J. Syrian Civil War: a systematic review of trauma casualty epidemiology. BMJ Mil Health 2020;166:261–5. https://doi.org/10.1136/JRAMC-2019-001304.
Khorram-Manesh A, Goniewicz K, Burkle FM, Robinson Y. Review of Military Casualties in Modern Conflicts—The Re-emergence of Casualties From Armored Warfare. Mil Med 2022;187:e313–21. https://doi.org/10.1093/MILMED/USAB108.
Cardi M, Ibrahim K, Alizai SW, Mohammad H, Garatti M, Rainone A, et al. Injury patterns and causes of death in 953 patients with penetrating abdominal war wounds in a civilian independent non-governmental organization hospital in Lashkargah, Afghanistan. World Journal of Emergency Surgery 2019;14:1–8. https://doi.org/10.1186/S13017-019-0272-Z/TABLES/9.
Wen Q, Liu D, Wang X, Zhang Y, Fang S, Qiu X, et al. A systematic review of ozone therapy for treating chronically refractory wounds and ulcers. Int Wound J 2022;19:853–70. https://doi.org/10.1111/IWJ.13687.
Cohn SM, Feinstein Ara. Battle Injuries of the Arteries in World War II: An Analysis of 2,471 Cases 2019:221–4. https://doi.org/10.1201/9781315147017-50.
Soderstrom MA, Blyth DM, Leigh Carson M, Campbell WR, Yabes MJM, Shaikh F, et al. Seasonality of Microbiology of Combat-Related Wounds and Wound Infections in Afghanistan. Mil Med 2023;188:304–10. https://doi.org/10.1093/MILMED/USAD115.
Staruch RMT, Hettiaratchy S. Warzone trauma and surgical infections. Surgery (Oxford) 2019;37:58–63. https://doi.org/10.1016/J.MPSUR.2018.12.001.
Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: A cellular perspective. Physiol Rev 2019;99:665–706. https://doi.org/10.1152/PHYSREV.00067.2017.
Probst S. Wound Care Nursing A person-centred approach n.d.
Vachhrajani V, Khakhkhar P. Science of Wound Healing and Dressing Materials. Science of Wound Healing and Dressing Materials 2019:1–180. https://doi.org/10.1007/978-981-32-9236-9/COVER.
Panayi AC, Reitblat C, Orgill DP. Wound Healing and Scarring. Total Scar Management: From Lasers to Surgery for Scars, Keloids, and Scar Contractures 2020:3–16. https://doi.org/10.1007/978-981-32-9791-3_1.
Mende K, Akers KS, Tyner SD, Bennett JW, Simons MP, Blyth DM, et al. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative. Mil Med 2022;187:42–51. https://doi.org/10.1093/MILMED/USAB131.
Muire PJ, Thompson MA, Christy RJ, Natesan S. Advances in Immunomodulation and Immune Engineering Approaches to Improve Healing of Extremity Wounds. International Journal of Molecular Sciences 2022, Vol 23, Page 4074 2022;23:4074. https://doi.org/10.3390/IJMS23084074.
Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of Acute and Chronic Wound Healing. Biomolecules 2021, Vol 11, Page 700 2021;11:700. https://doi.org/10.3390/BIOM11050700.
Hurlow J, Bowler PG. Acute and chronic wound infections: microbiological, immunological, clinical and therapeutic distinctions. J Wound Care 2022;31:436–45. https://doi.org/10.12968/JOWC.2022.31.5.436.
Mahmud F, Roy R, Mohamed MF, Aboonabi A, Moric M, Ghoreishi K, et al. Therapeutic evaluation of immunomodulators in reducing surgical wound infection. FASEB J 2022;36. https://doi.org/10.1096/FJ.202101019R.
Jones W, Gerogiorgis DI. A model-based performance analysis of integrated chromatography-ultrafilter separation systems for monoclonal antibody (mAb) manufacturing. Biochem Eng J 2024;206. https://doi.org/10.1016/j.bej.2024.109281.
Bayer V. An Overview of Monoclonal Antibodies. Semin Oncol Nurs 2019;35:150927. https://doi.org/10.1016/J.SONCN.2019.08.006.
Thompson KB, Krispinsky LT, Stark RJ. Late immune consequences of combat trauma: a review of trauma-related immune dysfunction and potential therapies. Mil Med Res [Internet]. 2019;6(1):11. Available from: http://dx.doi.org/10.1186/s40779-019-0202-0
Hatch-McChesney A, Smith TJ. Nutrition, immune function, and infectious disease in military personnel: A narrative review. Nutrients [Internet]. 2023;15(23):4999. Available from: http://dx.doi.org/10.3390/nu15234999
Zhang S-S, Li R-Q, Chen Z, Wang X-Y, Dumont AS, Fan X. Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res [Internet]. 2024;11(1). Available from: http://dx.doi.org/10.1186/s40779-024-00521-y
Strzelec M, Detka J, Mieszczak P, Sobocińska MK, Majka M. Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front Immunol [Internet]. 2023;14:1127704. Available from: http://dx.doi.org/10.3389/fimmu.2023.1127704
Mertowska P, Smolak K, Mertowski S, Grywalska E. Immunomodulatory role of interferons in viral and bacterial infections. Int J Mol Sci [Internet]. 2023;24(12). Available from: http://dx.doi.org/10.3390/ijms241210115
Owen AM, Fults JB, Patil NK, Hernandez A, Bohannon JK. TLR agonists as mediators of trained immunity: Mechanistic insight and immunotherapeutic potential to combat infection. Front Immunol [Internet]. 2021;11. Available from: http://dx.doi.org/10.3389/fimmu.2020.622614
Chen Y, Chau J, Yoon J, Hladky J. Rapid, label-free pathogen identification system for multidrug-resistant bacterial wound infection detection on military members in the battlefield. PLoS One [Internet]. 2022;17(5):e0267945. Available from: http://dx.doi.org/10.1371/journal.pone.0267945
Pruskowski KA, Mitchell TA, Kiley JL, Wellington T, Britton GW, Cancio LC. Diagnosis and management of invasive fungal wound infections in burn patients. European Burn Journal [Internet]. 2021;2(4):168–83. Available from: http://dx.doi.org/10.3390/ebj2040013
Millar EV, Bennett JW, Barin B, Carey PM, Law NN, English CE, et al. Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees. Vaccine [Internet]. 2021;39(23):3179–88. Available from: http://dx.doi.org/10.1016/j.vaccine.2021.04.031
Emuren L, the Infectious Disease Clinical Research Program HIV Working Group, Welles S, Macalino G, Evans AA, Polansky M, et al. Predictors of health-related quality of life among military HIV-infected individuals. Qual Life Res [Internet]. 2020;29(7):1855–69. Available from: http://dx.doi.org/10.1007/s11136-020-02441-5
Akers KS, Mende K, Cheatle KA, Zera WC, Yu X, Beckius ML, et al. Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis. BMC Infect Dis [Internet]. 2014;14(1):190. Available from: http://dx.doi.org/10.1186/1471-2334-14-190
Spampinato SF, Caruso GI, De Pasquale R, Sortino MA, Merlo S. The treatment of impaired wound healing in diabetes: Looking among old drugs. Pharmaceuticals (Basel) [Internet]. 2020;13(4):60. Available from: http://dx.doi.org/10.3390/ph13040060
Piipponen M, Li D, Landén NX. The immune functions of keratinocytes in skin wound healing. Int J Mol Sci [Internet]. 2020;21(22):8790. Available from: http://dx.doi.org/10.3390/ijms21228790
Ilyas F, James A, Khan S, Haider S, Ullah S, Darwish G, et al. Multidrug-resistant pathogens in wound infections: A systematic review. Cureus [Internet]. 2024; Available from: http://dx.doi.org/10.7759/cureus.58760
Parmanik A, Das S, Kar B, Bose A, Dwivedi GR, Pandey MM. Current treatment strategies against multidrug-resistant bacteria: A review. Curr Microbiol [Internet]. 2022;79(12). Available from: http://dx.doi.org/10.1007/s00284-022-03061-7
Foschi D, Yakushkina A, Cammarata F, Lamperti G, Colombo F, Rimoldi S, et al. Surgical site infections caused by multi-drug resistant organisms: a case–control study in general surgery. Updates Surg [Internet]. 2022;74(5):1763–71. Available from: http://dx.doi.org/10.1007/s13304-022-01243-3
Bui UT, Aitcheson SM, Boxall S, Parker T, Wood F, Murray R, et al. Research priorities for fundamental wound research in Australia: a scoping review protocol. Wound Pract Res [Internet]. 2021;29(4). Available from: http://dx.doi.org/10.33235/wpr.29.4.230-233
Nuutila K, Katayama S, Vuola J, Kankuri E. Human wound-healing research: Issues and perspectives for studies using wide-scale analytic platforms. Adv Wound Care (New Rochelle) [Internet]. 2014;3(3):264–71. Available from: http://dx.doi.org/10.1089/wound.2013.0502
Fallah N, Rasouli M, Amini MR. The current and advanced therapeutic modalities for wound healing management. J Diabetes Metab Disord [Internet]. 2021;20(2):1883–99. Available from: http://dx.doi.org/10.1007/s40200-021-00868-2
Zurawski DV, McLendon MK. Monoclonal antibodies as an antibacterial approach against bacterial pathogens. Antibiotics (Basel) [Internet]. 2020;9(4):155. Available from: http://dx.doi.org/10.3390/antibiotics9040155
La Guidara C, Adamo R, Sala C, Micoli F. Vaccines and monoclonal antibodies as alternative strategies to antibiotics to fight antimicrobial resistance. Int J Mol Sci [Internet]. 2024;25(10):5487. Available from: http://dx.doi.org/10.3390/ijms25105487
Troisi M, Marini E, Abbiento V, Stazzoni S, Andreano E, Rappuoli R. A new dawn for monoclonal antibodies against antimicrobial resistant bacteria. Front Microbiol [Internet]. 2022;13. Available from: http://dx.doi.org/10.3389/fmicb.2022.1080059
Chakraverty R, Bondyopadhyay J, Debnath T. The impact of monoclonal antibodies in preventing antimicrobial resistance (AMR). Ind J Pharm Pharmacol [Internet]. 2024;11(1):23–8. Available from: http://dx.doi.org/10.18231/j.ijpp.2024.005
McConnell MJ. Where are we with monoclonal antibodies for multidrug-resistant infections? Drug Discov Today [Internet]. 2019;24(5):1132–8. Available from: http://dx.doi.org/10.1016/j.drudis.2019.03.002
Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: Regulators of inflammation. Immunity [Internet]. 2019;50(4):796–811. Available from: http://dx.doi.org/10.1016/j.immuni.2019.03.022
Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, et al. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol [Internet]. 2023;13. Available from: http://dx.doi.org/10.3389/fimmu.2022.1069444
Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S. GM-CSF: A double-edged sword in cancer immunotherapy. Front Immunol [Internet]. 2022;13:901277. Available from: http://dx.doi.org/10.3389/fimmu.2022.901277
Borriello F, Galdiero MR, Varricchi G, Loffredo S, Spadaro G, Marone G. Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease. Int J Mol Sci 2019;20. https://doi.org/10.3390/IJMS20040834.
Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: A concise review. Front Immunol [Internet]. 2021;12. Available from: http://dx.doi.org/10.3389/fimmu.2021.752856
Silva AC, Lobo JMS. Cytokines and Growth Factors. In: Current Applications of Pharmaceutical Biotechnology. Cham: Springer International Publishing; 2019. p. 87–113. https://doi.org/10.1007/10_2019_105.
Jang D-I, Lee A-H, Shin H-Y, Song H-R, Park J-H, Kang T-B, et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci [Internet]. 2021;22(5):2719. Available from: http://dx.doi.org/10.3390/ijms22052719
Esposito S, Amirthalingam G, Bassetti M, Blasi F, De Rosa FG, Halasa NB, et al. Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy. Front Immunol [Internet]. 2023;14. Available from: http://dx.doi.org/10.3389/fimmu.2023.1162342
Kirillova A, Lado A, Blatt N. Application of monoclonal antibody drugs in treatment of COVID-19: A review. Bionanoscience [Internet]. 2022;12(4):1436–54. Available from: http://dx.doi.org/10.1007/s12668-022-00997-9
Timsit J-F, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med [Internet]. 2020;46(2):266–84. Available from: http://dx.doi.org/10.1007/s00134-020-05950-6
Ni J, Huang M, Zhang L, Wu N, Bai C, Chen L, et al. Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi [Internet]. 2021;24(3):141–60. Available from: http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.06
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
